Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9789
pubmed:dateCreated
2011-8-1
pubmed:databankReference
pubmed:abstractText
Depression is common in dementia but the evidence base for appropriate drug treatment is sparse and equivocal. We aimed to assess efficacy and safety of two of the most commonly prescribed drugs, sertraline and mirtazapine, compared with placebo.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1474-547X
pubmed:author
pubmed:copyrightInfo
Copyright © 2011 Elsevier Ltd. All rights reserved.
pubmed:issnType
Electronic
pubmed:day
30
pubmed:volume
378
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
403-11
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.
pubmed:affiliation
Institute of Psychiatry, Health Services and Population Research Department, King's College London, London, UK. sube.banerjee@kcl.ac.uk
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Review, Research Support, Non-U.S. Gov't, Multicenter Study